What is it about?
Creatine kinase is a popular biomarker for assessing muscle damage. However, there are quite a number of arguments which are pleading against the suitedness of the enzyme as a quantitative marker for assessing muscle damage.
Featured Image
Read the Original
This page is a summary of: Is creatine kinase an ideal biomarker in rhabdomyolysis? Reply to Lippi et al.: Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis (https://doi.org/10.1515/cclm-2018-0656), Clinical Chemistry and Laboratory Medicine (CCLM), April 2019, De Gruyter,
DOI: 10.1515/cclm-2018-1320.
You can read the full text:
Contributors
The following have contributed to this page
